| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba21d776c6f4591765c3922e556f72c2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 |
| filingDate |
2007-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_899586742809d6dc845d70887c965151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_253bc29ac6c75d80a21147bfbb0c80bf |
| publicationDate |
2020-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2796603-T3 |
| titleOfInvention |
Flu vaccines containing hemagglutinin and matrix proteins |
| abstract |
A method of preparing an immunogenic composition comprising the steps of: (i) cultivating the influenza virus in cell culture where trypsin is added to allow viral release; (ii) preparing an antigen composition from the viruses grown in step (i), wherein the antigen composition comprises hemagglutinin and matrix proteins not as a complete virion that forms a stable complex; and (iii) combining the antigen composition with a pharmaceutical carrier to give the immunogenic composition wherein the matrix protein has an amino acid sequence that is a fragment of a full-length M1 matrix protein amino acid sequence. |
| priorityDate |
2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |